Susan Galbraith, Executive VP, Oncology R&D, AstraZeneca

As­traZeneca on­col­o­gy R&D chief Su­san Gal­braith: 'Y­ou're go­ing to need or­thog­o­nal com­bi­na­tion­s'

 

Ear­li­er in the week we broad­cast our 4th an­nu­al Eu­ro­pean Bio­phar­ma Sum­mit with a great line­up of top ex­ecs. One of the one-on-one con­ver­sa­tions I set up was with Su­san Gal­braith, the on­col­o­gy re­search chief at As­traZeneca. In a wide-rang­ing dis­cus­sion, Gal­braith re­viewed the can­cer drug pipeline and key trends in­flu­enc­ing de­vel­op­ment work at the phar­ma gi­ant. You can watch the video, above, or stick with the script be­low. — JC

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Associate

Alexandria Real Estate Equities

Cambridge, MA, USA